Thomas Schwartz

Clinical trials

• A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

  Principal investigator · Completed · Phase 3

  State University of New York - Upstate Medical University

  2006–2010
• An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants

  Principal investigator · Completed

  State University of New York - Upstate Medical University

  2006–2009
• Xyrem for Treatment Refractory Insomnia Due to PTSD

  Principal investigator · Withdrawn · Phase 2

  State University of New York - Upstate Medical University

  2005–2006
• Aripiprazole as Augmentation for TRD

  Principal investigator · Completed · Phase 2

  State University of New York - Upstate Medical University

  2004–2005